Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody.

MLA

Saito, Yurina, et al. “Nano-Particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody.” Anticancer Research, vol. 43, no. 6, June 2023, pp. 2425–32. EBSCOhost, https://doi.org/10.21873/anticanres.16410.

APA

Saito, Y., Takahashi, T., Hiramatsu, K., Serada, S., Fujimoto, M., Ohkawara, T., Sugase, T., Nishigaki, T., Tanaka, K., Miyazaki, Y., Makino, T., Kurokawa, Y., Nakajima, K., Yamasaki, M., Ishii, K. J., Eguchi, H., Doki, Y., & Naka, T. (2023). Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody. Anticancer Research, 43(6), 2425–2432. https://doi.org/10.21873/anticanres.16410

Chicago

Saito, Yurina, Tsuyoshi Takahashi, Kosuke Hiramatsu, Satoshi Serada, Minoru Fujimoto, Tomoharu Ohkawara, Takahito Sugase, et al. 2023. “Nano-Particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody.” Anticancer Research 43 (6): 2425–32. doi:10.21873/anticanres.16410.